Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
Sunday 22 August 2021 4:13 pm  |  Updated:  Thursday 11 November 2021 11:33 am

Critically-ill Covid patients far less likely to die when lying on stomach while receiving oxygen

By: Michiel Willems

Add as a preferred source on Google

Critically-ill Covid-19 patients are far less likely to pass away or to require invasive ventilation if they are lying on their stomachs while receiving oxygen, according to a new global study.

The impact of the technique, known as awake prone positioning, was assessed in hospitals in six countries and involved more than 1,000 coronavirus patients requiring advanced breathing support.

The findings of the study, sponsored by NUI Galway, have been published in The Lancet Respiratory Medicine.

It was the first clinical trial of its kind into the practice of awake prone positioning and ran from April 2020 to January 2021.

It showed that putting patients in this position while they received high flow nasal cannula oxygen reduced death and the need for invasive mechanical ventilation.

Dr Bairbre McNicholas, honorary senior lecturer at NUI Galway and intensive care consultant at University Hospital Galway, said: “Providing an evidence base for what we do in the intensive care unit is critical so that we support and implement recommendations that work.

“This study, which was part of a global effort and was sponsored locally by NUI Galway and the Health Research Board Clinical Research Facility Galway, as part of its response to the Covid-19 pandemic, shows that clinical trials can be scaled up and done properly and efficiently during a pandemic and demonstrates what we can achieve when we work together.”

Read more

Alkermes to Present New Data on Alixorexton and LUMRYZ® (sodium oxybate) at SLEEP 2026, Highlighting Breadth of Sleep Medicine Research

Global study

The study involved 1,121 patients in the US, Canada, Mexico, France, Spain and Ireland, and it is the first time awake prone positioning has been studied to such an extent.

Some of the key findings of the study include that the wake prone positioning reduces death and the need for invasive intubation in patients with severe Covid-19 who require high flow nasal cannula oxygen.

The technique is safe and well-tolerated by patients and blood oxygen levels are significantly improved in patients who adopt awake prone positioning.

The longer patients can sustain being in prone positioning, the greater the success of the treatment and the less likely they are to need invasive mechanical ventilation.

Dr McNicholas said: “I tell patients that going on your tummy will improve the oxygen levels in your blood, that, although it is uncomfortable, the longer you can put up with this position, the less likely you will need to go on to require needing a breathing tube.”

Lisa Power was treated using awake prone positioning while a Covid patient at University Hospital Galway.

She said: “It really helped my breathing and made me much more comfortable without having to put me on a ventilator.”

Read more

Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Coronavirus
  • Pharmaceuticals

Trending Articles

  • Top Burnham adviser calls for capital gains and inheritance tax hikes

  • Clarkson’s Farm and why businesses must stop blaming the weather

  • Two solicitors linked to Post Office scandal charged with misconduct

  • Lloyd’s deputy chair: The City is a club in the best sense

  • Revealed: Secret Treasury plan to tax State Pension before it is paid out

More from City PM

  • Alkermes to Present New Data on Alixorexton and LUMRYZ® (sodium oxybate) at SLEEP 2026, Highlighting Breadth of Sleep Medicine Research

    Business Wire
  • Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera

    Business Wire
  • LivaNova Demonstrates 84.5% Cumulative Response Rate with PolySync Programming in OSPREY Study for Obstructive Sleep Apnea

    Business Wire
  • Alkermes Presents Detailed Positive Results From Vibrance-2 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 2 at SLEEP 2026

    Business Wire
  • cTAP Announces Novel Prognostic Score Developed for Duchenne Muscular Dystrophy Patients Offers Improved Prediction of Loss of Ambulation

    Business Wire
  • Award winning Medtech firm excels again

    Partner
    Unable to generate alt text without specific article content or context. Please provide more details or context.
  • Anocca has Dosed First Patients with Precision TCR-T Cell Therapy Targeting Mutant KRAS in Pancreatic Cancer

    Business Wire
  • Alkermes Announces Orphan Drug Designations for Alixorexton in the U.S. and Europe

    Business Wire

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy